Prognostic Markers in Pediatric Acute Liver Failure

Area of Science:

• Pediatric critical care medicine
• Hepatology
• Biomarker research

Background:

• Pediatric acute liver failure (PALF) is a rare but severe condition with high mortality.
• Accurate prognostic markers are crucial for optimizing organ allocation and patient management.
• Existing prognostic scores require validation in diverse pediatric populations.

Purpose of the Study:

• To evaluate the accuracy of various biomarkers and prognostic scores in predicting outcomes for pediatric acute liver failure (PALF).
• To identify reliable predictors of spontaneous recovery versus the need for liver transplantation or death.

Main Methods:

• Retrospective observational study of PALF patients admitted to a pediatric intensive care unit (PICU) over 28 years.
• Patients were categorized into spontaneous recovery (SR) and non-spontaneous recovery (NSR) groups.
• Analysis included lactate, ammonia, INR levels, and prognostic scores (LIU, PRISM, PALF-ds) for predictive accuracy.

Main Results:

• Lactate at admission (AUC 0.72), peak ammonia (AUC 0.72), and peak INR (AUC 0.70) showed acceptable accuracy in predicting non-spontaneous recovery (NSR).
• Lactate at admission was identified as an independent predictor of NSR.
• The LIU (AUC 0.73) and PRISM (AUC 0.71) scores demonstrated acceptable discrimination, while the PALF delta score (PALF-ds) showed lower capacity (AUC 0.63).

Conclusions:

• Lactate levels upon admission are a valuable and easily obtainable biomarker for predicting outcomes in pediatric acute liver failure (PALF).
• The prognostic performance of admission lactate is comparable to more complex scores like LIU and PRISM.
• The dynamic PALF-ds score demonstrated lower predictive value in this cohort than anticipated.